 |
For reference only; not available for CME credit
This independent CME activity is supported by an unrestricted
educational grant from Novartis Pharmaceuticals Corporation
|
Presentations
|
For dial-up, choose 56k, Cable/DSL, choose 300k | Requires RealPlayer  |
| 56k | 300k |
Overview: Goals of Therapy for Treatment of Advanced Breast Cancer
Daniel F. Hayes, MD |
| 56k | 300k |
Mechanisms of Endocrine Therapies
Professor Mitch Dowsett, PhD |
| 56k | 300k |
Use of Endocrine Therapies in Metastatic Disease
Clifford A. Hudis, MD |
| 56k | 300k |
Evolving Role of IV Bisphosphonates in Advanced Breast Cancer
Richard L. Theriault, DO, MBA
|
| 56k | 300k |
Aromatase Inhibitors in Nonmetastatic Disease
Matthew J. Ellis, MD, PhD, FRCP |
| 56k | 300k |
Question and Answer Session |
|
|
|